ORIX Corporation (IX) Stock Forecast
IX analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.00 / 5 from 1 analysts
- Price target
- $41.09 average of analyst targets
- Upside to target
- +11.4% from the latest close
- Next earnings
- November 11, 2026
- 52-week range
- $24.22 – $41.31
IX analyst ratings
1 analystsNumber of analysts at each rating.
IX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
IX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (FY2027) | $5.15 | $5.15 | $5.15 | $12.78 | −59.7% | 1 |
| Next fiscal year (FY2028) | $3.01 | $3.01 | $3.01 | $5.15 | −41.6% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
IX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $900.00B | $900.00B | $900.00B | +13.1% | 1 |
| Next quarter (Dec '26) | $1.16T | $1.16T | $1.16T | +37.4% | 1 |
| Current fiscal year (FY2027) | $3.45T | $3.41T | $3.57T | +382.9% | 5 |
| Next fiscal year (FY2028) | $3.65T | $3.42T | $4.08T | +5.7% | 6 |
IX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
IX revenue: reported and forecast
IX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (FY2027) | $3.14 | $0.00 | $4.90 | $4.90 | $5.15 | +64.3% | 1 up · 0 down |
| Next fiscal year (FY2028) | $2.98 | $0.00 | $3.00 | $3.00 | $3.01 | +0.8% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
IX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; IX beat in 7 of 11.
What analysts expect from IX
1 analysts cover ORIX; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $41.09, 11.4% above the latest close of $36.89. Analysts expect earnings of $5.15 per share for FY2027, −59.7% from a year earlier. For FY2028 the average estimate is $3.01 per share on revenue of $3.65 trillion. ORIX beat the EPS estimate in 7 of the last 11 quarters.
Related: IX income statement, IX key metrics, IX chart. See the IX stock overview for the latest quote and news.
IX forecast FAQ
What is ORIX's price target?
The average analyst price target for ORIX is $41.09, 11.4% above the latest close of $36.89.
Is ORIX a buy, hold or sell?
Of 1 analysts covering ORIX, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is ORIX's EPS forecast?
Analysts forecast $5.15 per share for FY2027 (range $5.15 to $5.15); for FY2028 the estimate is $3.01.
What is ORIX's revenue forecast?
The average revenue estimate for FY2027 is $3.45 trillion, growth of 382.9%; for FY2028 it is $3.65 trillion.
When does ORIX report earnings?
ORIX is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes.
Does ORIX usually beat earnings estimates?
ORIX reported EPS at or above the analyst estimate in 7 of the last 11 quarters.